Cargando…

Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines

Gene silencing by small interfering RNA (siRNA) is useful for analyzing the functions of human immune cells. However, the transfection of siRNA to human immune cells is difficult. Here, we used a multifunctional envelope-type nanodevice (MEND) containing YSK12-C4 (YSK12-MEND) to efficiently introduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Takashi, Kuroi, Moeka, Fujiwara, Yuki, Warashina, Shota, Sato, Yusuke, Harashima, Hideyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124971/
https://www.ncbi.nlm.nih.gov/pubmed/27892533
http://dx.doi.org/10.1038/srep37849
_version_ 1782469909445345280
author Nakamura, Takashi
Kuroi, Moeka
Fujiwara, Yuki
Warashina, Shota
Sato, Yusuke
Harashima, Hideyoshi
author_facet Nakamura, Takashi
Kuroi, Moeka
Fujiwara, Yuki
Warashina, Shota
Sato, Yusuke
Harashima, Hideyoshi
author_sort Nakamura, Takashi
collection PubMed
description Gene silencing by small interfering RNA (siRNA) is useful for analyzing the functions of human immune cells. However, the transfection of siRNA to human immune cells is difficult. Here, we used a multifunctional envelope-type nanodevice (MEND) containing YSK12-C4 (YSK12-MEND) to efficiently introduce siRNA to human immune cell lines, Jurkat, THP-1, KG-1 and NK92. The YSK12-MEND was transfected to human immune cell lines at a siRNA dose range of 1–30 nM, resulting that maximum gene silencing efficiencies at the mRNA level in Jurkat, THP-1, KG-1 and NK92 were 96%, 96%, 91% and 75%, respectively. The corresponding values for Lipofectamine RNAiMAX (RNAiMAX) were 37%, 56%, 43% and 19%, respectively. The process associated with cellular uptake played a role in effective gene silencing effect of the YSK12-MEND. The small size and high non-aggregability of the YSK12-MEND were advantageous for the cellular internalization of siRNA to immune cell lines. In the case of RNAiMAX, a drastic increase in particles size was observed in the medium used, which inhibited cellular uptake. The YSK12-MEND reported in herein appears to be appropriate for delivering siRNA to human immune cells, and the small particle size and non-aggregability are essential properties.
format Online
Article
Text
id pubmed-5124971
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51249712016-12-08 Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines Nakamura, Takashi Kuroi, Moeka Fujiwara, Yuki Warashina, Shota Sato, Yusuke Harashima, Hideyoshi Sci Rep Article Gene silencing by small interfering RNA (siRNA) is useful for analyzing the functions of human immune cells. However, the transfection of siRNA to human immune cells is difficult. Here, we used a multifunctional envelope-type nanodevice (MEND) containing YSK12-C4 (YSK12-MEND) to efficiently introduce siRNA to human immune cell lines, Jurkat, THP-1, KG-1 and NK92. The YSK12-MEND was transfected to human immune cell lines at a siRNA dose range of 1–30 nM, resulting that maximum gene silencing efficiencies at the mRNA level in Jurkat, THP-1, KG-1 and NK92 were 96%, 96%, 91% and 75%, respectively. The corresponding values for Lipofectamine RNAiMAX (RNAiMAX) were 37%, 56%, 43% and 19%, respectively. The process associated with cellular uptake played a role in effective gene silencing effect of the YSK12-MEND. The small size and high non-aggregability of the YSK12-MEND were advantageous for the cellular internalization of siRNA to immune cell lines. In the case of RNAiMAX, a drastic increase in particles size was observed in the medium used, which inhibited cellular uptake. The YSK12-MEND reported in herein appears to be appropriate for delivering siRNA to human immune cells, and the small particle size and non-aggregability are essential properties. Nature Publishing Group 2016-11-28 /pmc/articles/PMC5124971/ /pubmed/27892533 http://dx.doi.org/10.1038/srep37849 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Nakamura, Takashi
Kuroi, Moeka
Fujiwara, Yuki
Warashina, Shota
Sato, Yusuke
Harashima, Hideyoshi
Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
title Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
title_full Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
title_fullStr Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
title_full_unstemmed Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
title_short Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
title_sort small-sized, stable lipid nanoparticle for the efficient delivery of sirna to human immune cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124971/
https://www.ncbi.nlm.nih.gov/pubmed/27892533
http://dx.doi.org/10.1038/srep37849
work_keys_str_mv AT nakamuratakashi smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines
AT kuroimoeka smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines
AT fujiwarayuki smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines
AT warashinashota smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines
AT satoyusuke smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines
AT harashimahideyoshi smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines